Larimar Therapeutics, Inc.
LRMR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374690
In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Larimar Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 103 | 116 | +13 |
| Shares | 60.8M | 62.3M | +1.48M (+2.4%) |
| Value | $131.9M | $180.1M | +$48.2M (+36.6%) |
New holders (30)
Institutions that held Larimar Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (17)
Institutions that held Larimar Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Janus Henderson Group PLC | 5,571,963 | $13.1M |
| Cubist Systematic Strategies, LLC | 354,232 | $761.6K |
| Altium Capital Management LP | 273,204 | $587.4K |
| Jump Financial, LLC | 86,350 | $185.7K |
| Ikarian Capital, LLC | 58,526 | $125.8K |
| Acadian Asset Management LLC | 53,239 | $113.0K |
| Alps Advisors Inc | 47,460 | $102.0K |
| Brevan Howard Capital Management LP | 31,880 | $68.5K |
| Virtus Investment Advisers, Inc. | 26,869 | $57.8K |
| Corebridge Financial, Inc. | 20,609 | $44.3K |
| Walleye Capital LLC | 17,166 | $36.9K |
| Jain Global LLC | 16,729 | $36.0K |
| SG Americas Securities, LLC | 14,974 | $32.0K |
| Boothbay Fund Management, LLC | 13,731 | $29.5K |
| Quadrature Capital Ltd | 10,242 | $21.9K |
| California State Teachers Retirement System | 3,048 | $6.55K |
| Point72 (DIFC) Ltd | 127 | $274 |